Drug intelligence / Profile preview

Bai Jin Pill

Development stage
Unknown
Lead developer
Jinsheng Da Ren Tang
Administration
Oral
01

Overview

Bai Jin Pill (also known as Baijin Wan) is a traditional Chinese medicine (TCM) formula developed and manufactured by Jinsheng Da Ren Tang (Tianjin Pharmaceutical Da Ren Tang Group). It is composed of two primary active ingredients: Yujin (*Curcuma aromatica* or *Curcuma wenyujin*) and Alumen (alum). Bai Jin Pill is traditionally used to clear phlegm, open the sensory orifices, clear the heart, and calm the spirit. It is approved in China for the treatment of phlegm-qi obstruction, epilepsy, mania, sudden collapse, and spitting of saliva or froth. Modern pharmacological research indicates that curcumin, a key active component of Yujin, modulates receptor-type tyrosine-protein phosphatase zeta (PTPRZ1) activity, thereby regulating neuroinflammation and providing neuroprotective effects in epilepsy and associated cognitive dysfunction.

Brand names
Bai Jin Pill
Other names
Baijin PillBaijin Wan白金丸
02

Targets

PTPRZ1 (Protein tyrosine phosphatase receptor type Z1)

Beyond the preview

Go deeper on Bai Jin Pill.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Bai Jin Pill.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call